The Los Angeles-based medical device company BioSig Technologies, Inc. announced in a press release the FDA 510(k) clearance of its PURE EP System, which is designed to aid electrophysiology procedures, such as cardiac...more
Federal Circuit Summaries -
Before Lourie, Dyk, and Taranto. Appeal from the District Court for the District of Delaware.
Summary: A passing reference in the prior art to a formulation containing the claimed active...more
According to the Straits Times, QT Vascular, a Singapore-based medical device company, reached an asset purchase and option agreement to sell its intellectual property rights to some of its non-drug coated coronary products,...more
Federal Circuit Summaries -
Before Moore, Schall, and O’Malley. Appeal from the Northern District of Illinois.
Summary: A plaintiff need not prove its case of patent infringement at the pleading stage. To the extent a...more
3/1/2018
/ Amended Complaints ,
Appeals ,
Claim Construction ,
Dismissals ,
Federal Pleading Requirements ,
Federal Rule 12(b)(6) ,
Method Claims ,
Motion to Dismiss ,
Patent Infringement ,
Patents ,
Reversal ,
Twombly/Iqbal Pleading Standard
The United States District Court of Western District of Washington entered a judgment in a trade secret case, Verasonics, Inc. v. Alpinion Medical Systems Co., Ltd. (Case No. 2:14-cv-01820-JCC). The district court confirmed...more
UCLA announced that scientists from UCLA and University of Connecticut designed a new form of energy storage for powering implantable medical devices that do not require a battery. According to the announcement, this design...more
The Federal Circuit held that a rat study in a provisional application and a conversion method in an uncited reference did not support the claimed human dosage form in Los Angeles Biomed. Research Inst. v. Eli Lilly & Co.,...more
On February 14, 2017, U.S. District Judge Michael Mosman of the United States District Court, District of Oregon granted a Joint Stipulated Motion for Dismissal with Prejudice submitted by Plaintiffs Smith & Nephew, Inc. and...more
2/20/2017
/ Appeals ,
Damages ,
Dismissal With Prejudice ,
JMOL ,
Jury Verdicts ,
Life Sciences ,
Patent Infringement ,
Patents ,
Pharmaceutical Patents ,
Reinstatement ,
Reversal ,
Willful Infringement
The U.S. Food and Drug Administration (FDA) has approved Abbott’s Tecnis Symfony Intraocular Lenses (IOL) for treating cataracts. According to Abbott, the Tecnis Symfony lenses are currently the only lenses in the United...more
St. Jude Medical, Inc. recently announced the U.S. launch and the first U.S. implant of its Quadra Assure MP™ cardiac resynchronization therapy defibrillator (CRT-D). The Quadra Assura MP™ features St. Jude Medical’s...more
Swiss biotech company Roche announced on December 21, 2015 that the FDA has approved the Cobas® 6800 and 8800 Systems from its Pleasanton, California-based Roche Molecular Diagnostics (RMD) for the Cobas® HIV-1 viral load...more
St. Jude Medical, Inc. recently announced that it has completed its acquisition of Thoratec Corporation. In July 2015, St. Jude Medical announced its offer to buy Thoratec shares at $63.50 per share. The transaction is valued...more